ꢁꢀꢀꢀ
R. Teimuri-Mofrad et al.: Synthesis of pyrano[3,2-b]pyransꢂ ꢂ5
4.52–4.59 (m, 2H, CH2), 4.91 (s, 1H, methin-H), 6.60 (s, 1H, Ar-H), 7.32– [11] He, M.; Yang, N.; Sun, C.; Yao, X.; Yang, M. Modification and
7.36 (m, 4H, Ar-H and NH2), 7.46 (d, 2H, Jꢀ=ꢀ8.34 Hz, Ar-H); 13C NMR: δ
39.6, 40.7, 55.2, 114.9, 119.0, 128.9, 129.8, 132.6, 136.6, 139.5, 149.2, 159.1,
161.8, 169.4. Anal. Calcd for C16H10Cl2N2O3: C, 55.04; H, 2.89; N, 8.02.
Found: C, 54.85; H, 2.92; N, 8.10.
biological evaluation of novel 4-hydroxy-pyrone derivatives as
non-peptidic HIV-1 protease inhibitors. Med. Chem. Res. 2011,
20, 200–209.
[12] da Rocha, D. R.; de Souza, A. C.; Resende, J. A.; Santos, W. C.; dos
Santos, E. A.; Pessoa, C.; de Moraes, M. O.; Costa-Lotufo, L. V.;
Montenegro, R. C.; Ferreira, V. F. Synthesis of new 9-hydroxy-α-
and 7-hydroxy-β-pyrannaphthoquinones and cytotoxicity against
cancer cell lines. Org. Biomol. Chem. 2011, 9, 4315–4322.
2-Amino-6-(chloromethyl)-8-oxo-4-(thiophen-2-yl)-4,8-dihy-
dropyrano[3,2-b]pyran-3-carbonitrile (6f)ꢁWhite powder; mp
190–192°C ; IR: 3381, 3312, 3028, 2925, 2200, 1640, 1598 cm−1; 1H NMR:
δ 4.58–4.65 (m, 2H, CH2), 5.21 (s, 1H, methin-H), 6.62 (s, 1H, Ar-H), [13] Shahrisa, A.; Esmati, S.; Miri, R.; Firuzi, O.; Edraki, N.; Nejati,
7.02 (t, Jꢀ=ꢀ4.39 Hz, 1H, Ar-H), 7.09 (s, 1H, Ar-H), 7.37 (s, 2H, NH2),
7.52 (d, Jꢀ=ꢀ4.75 Hz, 1H, Ar-H); 13C NMR: δ 35.5, 40.8, 55.6, 115.0, 119.0,
126.1, 126.4, 127.3, 135.9, 144.6, 149.1, 159.3, 161.9, 169.4. Anal. Calcd for
C14H9ClN2O3S: C, 52.43; H, 2.83; N, 8.73. Found: C, 52.19; H, 2.87; N,
8.80.
M. Cytotoxic activity assessment, QSAR and docking study of
novel bis-carboxamide derivatives of 4-pyrones synthesized
by Ugi four-component reaction. Eur. J. Med. Chem. 2013, 66,
388–399.
[14] Hussain, H.; Aziz, S.; Schulz, B.; Krohn, K. Synthesis of a
4H-anthra[1,2-b]pyran derivative and its antimicrobial activity.
Nat. Prod. Commun. 2011, 6, 841–843.
[15] Schiller, R.; Tichotová, L.; Pavlík, J.; Buchta, V.; Melichar, B.;
Votruba, I.; Kuneš, J.; Špulák, M.; Pour, M. 3,5-Disubstituted
pyranone analogues of highly antifungally active furanones:
Conversion of biological effect from antifungal to cytostatic.
Bioorg. Med. Chem. Lett. 2010, 20, 7358–7360.
[16] Bisht, S. S.; Jaiswal, N.; Sharma, A.; Fatima, S.; Sharma, R.;
Rahuja, N.; Srivastava, A.; Bajpai, V.; Kumar, B.; Tripathi, R. P.
A convenient synthesis of novel pyranosyl homo-C-nucleosides
and their antidiabetic activities. Carbohydr. Res. 2011, 346,
1191–1201.
[17] Wang, S.; Milne, G.; Yan, X.; Posey, I. J.; Nicklaus, M. C.;
Graham, L.; Rice, W. G. Discovery of novel, non-peptide HIV-1
protease inhibitors by pharmacophore searching. J. Med.
Chem. 1996, 39, 2047–2054.
[18] Wang, Y.; Mo, S.-Y.; Wang, S.-J.; Li, S.; Yang, Y.-C.; Shi, J.-G. A
unique highly oxygenated pyrano[4,3-c][2]benzopyran-1,6-di-
one derivative with antioxidant and cytotoxic activities from the
fungus phellinusigniarius. Org. Lett. 2005, 7, 1675–1678.
[19] Shahrisa, A.; Miri, R.; Esmati, S.; Saraei, A.; Mehdipour, A.;
Sharifi, M. Synthesis and calcium channel antagonist activity
of novel 1,4-dihydropyridine derivatives possessing 4-pyrone
moieties. Med. Chem. Res. 2012, 21, 284–292.
[20] Osman, S.; Albert, B. J.; Wang, Y.; Li, M.; Czaicki, N. L.; Koide,
K. Structural requirements for the antiproliferative activity of
pre-mRNA splicing inhibitor FR901464. Chem. Eur. J. 2011, 17,
895–904.
Acknowledgments: The authors thank Research Affairs of
the University of Tabriz for financial support.
References
[1] Rossi, L. M.; Silva, F. P.; Vono, L. L.; Kiyohara, P. K.; Duarte, E.
L.; Itri, R.; Landers, R.; Machado, G. Superparamagnetic nan-
oparticle-supported palladium: a highly stable magnetically
recoverable and reusable catalyst for hydrogenation reactions.
Green Chem. 2007, 9, 379–385.
[2] Shahrisa, A.; Esmati, S. Three novel sequential reactions for
the facile synthesis of a library of bisheterocyclespossess-
ing the 3-aminoimidazo[1,2-a]pyridine core catalyzed by
bismuth(III) chloride. Synlett 2013, 24, 595–602.
[3] Polshettiwar, V.; Luque, R.; Fihri, A.; Zhu, H.; Bouhrara, M.;
Basset, J.-M. Magnetically recoverable nanocatalysts. Chem.
Rev. 2011, 111, 3036–3075.
[4] Gawande, M. B.; Branco, P. S.; Varma, R. S. Nano-magnetite
(Fe3O4) as a support for recyclable catalysts in the develop-
ment of sustainable methodologies. Chem. Soc. Rev. 2013, 42,
3371–3393.
[5] Baig, R. N.; Varma, R. S. Organic synthesis via magnetic
attraction: benign and sustainable protocols using magnetic
nanoferrites. Green. Chem. 2013, 15, 398–417.
[6] Sadeghzadeh, S. M.; Daneshfar, F.; Malekzadeh, M.
Manganese(III) salen complex immobilized on Fe3O4magnetic
nanoparticles: the efficient, green and reusable nanocatalyst.
Chin. J. Chem. 2014, 32, 349–355.
[7] Shylesh, S.; Schünemann, V.; Thiel, W. R. Magnetically separa-
ble nanocatalysts: bridges between homogeneous and hetero-
geneous catalysis. Angew. Chem. Int. Ed. 2010, 49, 3428–3459.
[8] Xin, B.; Hao, J. Imidazolium-based ionic liquids grafted on solid
surfaces. Chem. Soc. Rev. 2014, 43, 7171–7187.
[9] Rashinkar, G.; Salunkhe, R. J. Ferrocene labelled supported
ionic liquid phase (SILP) containing organocatalytic anion for
multi-component synthesis. J. Mol. Catal. A-Chem. 2010, 316,
146–152.
[21] Kesten, S. R.; Heffner, T. G.; Johnson, S. J.; Pugsley, T. A.;
Wright, J. L.; Wise, L. D. Design, Synthesis, and evaluation of
chromen-2-ones as potent and selective human dopamine D4
antagonists. J. Med. Chem. 1999, 42, 3718–3725.
[22] Brühlmann, C.; Ooms, F.; Carrupt, P.-A.; Testa, B.; Catto, M.;
Leonetti, F.; Altomare, C.; Carotti, A. Coumarins derivatives
as dual inhibitors of acetylcholinesterase and monoamine
oxidase. J. Med. Chem. 2001, 44, 3195–3198.
[23] Banitaba, S. H.; Safari, J.; Baghbanian, S. M.; Rezaei, N.;
Tashakkorian, H. Nanozeoliteclinoptilolite as a highly efficient
heterogeneous catalyst for the synthesis of various 2-amino-
4H-chromene derivatives in aqueous media. Green Chem.
2013, 15, 3446–3458.
[10] Rashinkar, G.; Kamble, S.; Kumbhar, A.; Salunkhe, R. An expe-
ditious synthesis of homoallylic alcohols using Brønsted acidic
supported ionic liquid phase catalyst with pendant ferrocenyl
group. Catal. Commun. 2011, 12, 1442–1447.
[24] Asghari, S.; Baharfar, R.; Alimi, M.; Ahmadipour, M.; Mohseni,
M. Synthesis and antibacterial activities of pyrano[3,2-b]pyra-
nones from kojic acid, ethyl cyanoacetate, and benzaldehydes
in aqueous K2CO3. Monatsh. Chem. 2014, 145, 1337–1342.
Brought to you by | University of Gothenburg
Authenticated
Download Date | 11/21/17 1:54 PM